Led by expert international faculty and specifically designed for all healthcare professionals in countries throughout Europe involved in the treatment of heart failure patients.
Heart Education Europe consists of dynamic, interactive and multi-format educational activities, including journal clubs, myth buster animations, case-studies and symposia.
Why join?
|
Be notified of the latest content from the Heart Education Europe programme and gain CPD points.
The effect of empagliflozin on heart failure and renal outcomes by baseline diabetes status: an analysis of the EMPEROR-Reduced trial’ – live webinar’ has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 1 category 1 (external) CPD credit(s).
Get started for free